comparemela.com

Latest Breaking News On - Darioa paggiarino - Page 1 : comparemela.com

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up Following Insider Buying Activity

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up Following Insider Buying Activity
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Darioa-paggiarino
Franklin-resources-inc
First-turn-management
News-ratings-for-eyepoint-pharmaceuticals-daily
Nasdaq
Eyepoint-pharmaceuticals
Securities-exchange-commission
Jpmorgan-chase-co
Eyepoint-pharmaceuticals-inc
Eyepoint-pharmaceuticals-stock
Institutional-investors-weigh-in-on-eyepoint-pharmaceuticals

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Down to $21.53

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $21.53, but opened at $20.26. EyePoint Pharmaceuticals shares last traded at $20.84, with a volume of 50,221 shares changing hands. Analyst Ratings Changes Several research analysts recently commented on the company. Mizuho […]

Darioa-paggiarino
Nasdaq
News-ratings-for-eyepoint-pharmaceuticals-daily
Eyepoint-pharmaceuticals-company-profile
Eyepoint-pharmaceuticals
Jump-financial
Scotia-capital-inc
Insider-activity-at-eyepoint-pharmaceuticals
Eyepoint-pharmaceuticals-inc
Jpmorgan-chase-co
Securities-exchange-commission

EyePoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Passes Above Two Hundred Day Moving Average of $17.27

EyePoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Passes Above Two Hundred Day Moving Average of $17.27
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Darioa-paggiarino
Deutsche-bank
Tower-research-capital
Insider-transactions-at-eyepoint-pharmaceuticals
Nasdaq
Securities-exchange-commission
Jpmorgan-chase-co
American-international-group-inc
Eyepoint-pharmaceuticals-inc

Brokerages Set EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Price Target at $33.86

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has received an average recommendation of “Buy” from the seven brokerages that are presently covering the stock, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year […]

United-states
American
Darioa-paggiarino
Tower-research-capital
Securities-exchange-commission
Analyst-recommendations-for-eyepoint-pharmaceuticals
Institutional-investors-weigh-in-on-eyepoint-pharmaceuticals
American-international-group-inc
Nasdaq
News-ratings-for-eyepoint-pharmaceuticals-daily
Investment-advisers

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives $33.86 Consensus Price Target from Brokerages

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has been assigned a consensus rating of “Buy” from the seven ratings firms that are presently covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokers that have issued ratings on the stock […]

Darioa-paggiarino
Analyst-recommendations-for-eyepoint-pharmaceuticals
News-ratings-for-eyepoint-pharmaceuticals-daily
Franklin-resources-inc
Securities-exchange-commission
Vanguard-group-inc
Jpmorgan-chase-co
Eyepoint-pharmaceuticals
Eyepoint-pharmaceuticals-inc
Pricet-rowe-associates-inc
Eyepoint-pharmaceuticals-price-performance

vimarsana © 2020. All Rights Reserved.